Unit News from Breast Cancer

Clínic Barcelona

Clínic Barcelona

January 25 2022 2022-01-25

Developed the first genomic test for personalized HER2+ breast cancer treatments

The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.

Clínic Barcelona

Clínic Barcelona

March 29 2021 2021-03-29

A molecular classification predicts the prognosis and the benefit of a cell cycle inhibitor in metastatic breast cancer

In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity of1